no shop currency defined Top snippets

Institution: In the first half of 2024, the scale of China's edge cloud market increased by 21% year-on-year. Recently, the latest report "China Edge Cloud Market Tracking Research, 2024H1" released by International Data Corporation (IDC) shows that in the first half of 2024, the scale of China's edge cloud market totaled 5.48 billion yuan, with a year-on-year growth rate of 21.0%. Among them, the market scale of edge public cloud services, edge exclusive cloud services and edge cloud solutions reached RMB 3.00 billion, RMB 970 million and RMB 1.50 billion respectively. Internet audio and video distribution and real-time interaction based on edge resources, edge game clothes, cloud terminals and cloud games, cloud network services, and lightweight IT architecture migration of local industry customers are the core driving forces for market growth in this period.Sony group's share price hit a record high in intraday trading.Chen Xiaodong, Vice Foreign Minister, met with Gandson, Permanent Secretary of Zambia's Foreign Ministry. According to official website, Vice Foreign Minister Chen Xiaodong met with Gandson, Permanent Secretary of Zambia's Foreign Ministry, who was visiting China on December 11th, 2024.

According to a survey conducted by the Monetary Authority of Singapore, Singapore's GDP growth rate is expected to be 3.6% in 2024 (previously 2.6%) and 3.1% in the fourth quarter of 2024 (previously 2.2%).The Shanghai Municipal Science and Technology Commission issued the Action Plan for Promoting the Innovative Development of Scientific Instruments and Reagents in Shanghai (2025-2027), which was formulated by the Shanghai Municipal Science and Technology Commission to promote the innovative development of the scientific instruments and reagents industry in Shanghai. Adhere to the working idea of "following the development law, facing the needs of the industry, strengthening superior products, cultivating and expanding enterprises, and creating a development ecology", adhere to the product as the traction, strengthen key core technology research, vigorously cultivate first-class enterprises, and promote the high-quality development of the industry. By 2027, 1-2 technical test and verification platforms will be built, and more than 5 application scenarios and user experience centers will be built. The scientific and technological innovation ability of scientific instruments and scientific research reagents in our city will be further enhanced, and the industrial innovation ecology will be further improved. More than 5 leading scientific and technological enterprises in subdivided tracks will be cultivated, and more than 5 scientific instruments and 10 scientific research reagents reaching the international leading level will be formed. The industrial output value of scientific instruments and scientific research reagents will be about 45 billion yuan.Japan Life Insurance announced that it would spend $8.2 billion to acquire the life insurance company Resolution Life. On December 11th, Japan Life Insurance Mutual announced that it would spend about $8.2 billion to acquire the remaining 77% shares of the life insurance company Resolution Life. The transaction is expected to be completed in the second half of 2025. On the same day, Japan Life announced that it would acquire the remaining 20% shares of MLC Life Insurance from National Bank of Australia (NAB) and integrate MLC with Resolution Life.

* ExxonMobil: It is estimated that the annual cash capital expenditure will reach $28-33 billion from 2026 to 2030.Indian Rupee fell below 84.8575 against the US dollar, hitting an all-time low.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.